Jeff Geschwind, MD is the innovative founder of Cage Pharma. His entrepreneurial drive focuses on creating groundbreaking cancer drugs that target tumor metabolism. This research offers new hope for treating aggressive cancers by disrupting the unique way they generate energy to grow. https://about.me/jeff.geschwind